Warfarin Sodium Tablet
Product Images NDC 70518-1492

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Warfarin Sodium (NDC 70518-1492). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Warfarin Sodium 2.5mg 70518 1492 00

Label for Warfarin Sodium 2.5 mg oral tablets, quantity 30, manufactured by Teva, Frazer, PA, and repackaged by RemedyRepack Inc., Indiana, PA. The label states it is a prescription drug with a warning about serious bleeding from overdose. Storage instructions and contact information for RemedyRepack are included.*

FDA Label Image

Image 1

Chemical structure of Warfarin Sodium showing its molecular components including benzene rings, an ether linkage, sodium carboxylate group, and ketone moiety, consistent with the active ingredient in the tablet form of the drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.